AU542795B2 - Creación de Inventos y Patentes con Inteligencia Artificial

AU542795B2 – Alpha amylase inhibitor
– Google Patents

AU542795B2 – Alpha amylase inhibitor
– Google Patents
Alpha amylase inhibitor

Info

Publication number
AU542795B2

AU542795B2
AU76150/81A
AU7615081A
AU542795B2
AU 542795 B2
AU542795 B2
AU 542795B2
AU 76150/81 A
AU76150/81 A
AU 76150/81A
AU 7615081 A
AU7615081 A
AU 7615081A
AU 542795 B2
AU542795 B2
AU 542795B2
Authority
AU
Australia
Prior art keywords
alpha amylase
amylase inhibitor
inhibitor
alpha
amylase
Prior art date
1980-10-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Ceased

Application number
AU76150/81A
Other versions

AU7615081A
(en

Inventor
Heinz Aschauer
Gerhard Braunitzer
Miroslav Mracek
Laszlo Vertesy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hoechst AG

Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1980-10-09
Filing date
1981-10-08
Publication date
1985-03-14

1980-10-09
Priority claimed from DE19803038130
external-priority
patent/DE3038130A1/en

1981-02-26
Priority claimed from DE19813107106
external-priority
patent/DE3107106A1/en

1981-10-08
Application filed by Hoechst AG
filed
Critical
Hoechst AG

1982-04-22
Publication of AU7615081A
publication
Critical
patent/AU7615081A/en

1985-03-14
Application granted
granted
Critical

1985-03-14
Publication of AU542795B2
publication
Critical
patent/AU542795B2/en

2001-10-08
Anticipated expiration
legal-status
Critical

Status
Ceased
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07K—PEPTIDES

C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA

C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor

C12N1/20—Bacteria; Culture media therefor

C12N1/205—Bacterial isolates

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K38/00—Medicinal preparations containing peptides

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C – C12Q, RELATING TO MICROORGANISMS

C12R2001/00—Microorganisms ; Processes using microorganisms

C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

C12R2001/465—Streptomyces

Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC

Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

Y10S930/00—Peptide or protein sequence

Y10S930/01—Peptide or protein sequence

Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

AU76150/81A
1980-10-09
1981-10-08
Alpha amylase inhibitor

Ceased

AU542795B2
(en)

Applications Claiming Priority (4)

Application Number
Priority Date
Filing Date
Title

DE19803038130

DE3038130A1
(en)

1980-10-09
1980-10-09
Alpha amylase inactivators for Streptomyces tendae – useful for lowering blood sugar levels

DE30381307

1980-10-09

DE31071066

1981-02-26

DE19813107106

DE3107106A1
(en)

1981-02-26
1981-02-26
alpha -Amylase inactivator and process for its preparation

Publications (2)

Publication Number
Publication Date

AU7615081A

AU7615081A
(en)

1982-04-22

AU542795B2
true

AU542795B2
(en)

1985-03-14

Family
ID=25788382
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU76150/81A
Ceased

AU542795B2
(en)

1980-10-09
1981-10-08
Alpha amylase inhibitor

Country Status (9)

Country
Link

US
(1)

US4451455A
(en)

EP
(1)

EP0049847B1
(en)

AU
(1)

AU542795B2
(en)

CA
(1)

CA1172978A
(en)

DE
(1)

DE3169418D1
(en)

DK
(1)

DK446481A
(en)

ES
(1)

ES8207217A1
(en)

FI
(1)

FI813108L
(en)

NO
(1)

NO813407L
(en)

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU580973B2
(en)

1984-01-21
1989-02-09
Hoechst Aktiengesellschaft
Novel polypeptides with an «-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products

Families Citing this family (30)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPS5885899A
(en)

1981-11-16
1983-05-23
Fujirebio Inc
Amylase inhibitor and its preparation

DE3331860A1
(en)

1983-09-03
1985-03-21
Hoechst Ag, 6230 Frankfurt
Process for the preparation of tendamistat

DE3738541A1
(en)

1987-11-13
1989-05-24
Hoechst Ag

METHOD FOR INSULATING AND CLEANING HIRUDINE

DE3536182A1
(en)

1985-10-10
1987-04-16
Hoechst Ag

PROMOTOR ARRANGEMENT FOR STREPTOMYCETE VECTORS

WO1996012730A1
(en)

1994-10-20
1996-05-02
Industrial Research Limited
Separation of amino acids and peptides from protein hydrolysates

EP1689383B1
(en)

2003-11-19
2012-10-31
Metabasis Therapeutics, Inc.
Novel phosphorus-containing thyromimetics

US7262318B2
(en)

2004-03-10
2007-08-28
Pfizer, Inc.
Substituted heteroaryl- and phenylsulfamoyl compounds

US20050288340A1
(en)

2004-06-29
2005-12-29
Pfizer Inc
Substituted heteroaryl- and phenylsulfamoyl compounds

JP2008520642A
(en)

2004-11-23
2008-06-19
ワーナー−ランバートカンパニーリミテッドライアビリティーカンパニー

7- (2H-pyrazol-3-yl) -3,5-dihydroxy-heptanoic acid derivatives as HMG-CoA reductase inhibitors for the treatment of lipemia

US7741317B2
(en)

2005-10-21
2010-06-22
Bristol-Myers Squibb Company
LXR modulators

US7888376B2
(en)

2005-11-23
2011-02-15
Bristol-Myers Squibb Company
Heterocyclic CETP inhibitors

US8404896B2
(en)

2006-12-01
2013-03-26
Bristol-Myers Squibb Company
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases

CN103601792B
(en)

2007-06-04
2016-06-29
协同医药品公司
It is effective to the guanylate cyclase agonist of gastrointestinal dysfunction, inflammation, cancer and other diseases treatment

US8969514B2
(en)

2007-06-04
2015-03-03
Synergy Pharmaceuticals, Inc.
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases

CA2930674A1
(en)

2008-06-04
2009-12-10
Synergy Pharmaceuticals Inc.
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

AU2009270833B2
(en)

2008-07-16
2015-02-19
Bausch Health Ireland Limited
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders

US20120046364A1
(en)

2009-02-10
2012-02-23
Metabasis Therapeutics, Inc.
Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

CA2799708A1
(en)

2010-05-21
2011-11-24
Pfizer Inc.
2-phenyl benzoylamides

WO2012027331A1
(en)

2010-08-27
2012-03-01
Ironwood Pharmaceuticals, Inc.
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

US9616097B2
(en)

2010-09-15
2017-04-11
Synergy Pharmaceuticals, Inc.
Formulations of guanylate cyclase C agonists and methods of use

US20130345392A1
(en)

2011-03-04
2013-12-26
Pfizer Inc
Edn3-like peptides and uses thereof

US20150050371A1
(en)

2012-03-09
2015-02-19
Biotropics Malaysia Berhad
Extract Formulations of Rhodamnia Cinerea And Uses Thereof

AU2014235209B2
(en)

2013-03-15
2018-06-14
Bausch Health Ireland Limited
Guanylate cyclase receptor agonists combined with other drugs

AU2014235215A1
(en)

2013-03-15
2015-10-01
Synergy Pharmaceuticals Inc.
Agonists of guanylate cyclase and their uses

CA2909442A1
(en)

2013-04-17
2014-10-23
Pfizer Inc.
N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases

CN105764916B
(en)

2013-06-05
2021-05-18
博士医疗爱尔兰有限公司
Ultra-pure agonists of guanylate cyclase C, methods of making and using the same

AU2015308350B2
(en)

2014-08-29
2020-03-05
Tes Pharma S.R.L.
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

WO2016055901A1
(en)

2014-10-08
2016-04-14
Pfizer Inc.
Substituted amide compounds

TWI767945B
(en)

2016-10-14
2022-06-21
義大利商Ｔｅｓ製藥（股份）責任有限公司
INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

WO2020104456A1
(en)

2018-11-20
2020-05-28
Tes Pharma S.R.L
INHIBITORS OF α-AMINO-β-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

JPS5125232B1
(en)

1965-02-24
1976-07-29

DE2701890C2
(en)

1977-01-19
1983-08-04
Hoechst Ag, 6230 Frankfurt

Streptomycete peptic glycoside hydrolase inhibitor and its use

1981

1981-10-02
ES
ES505959A
patent/ES8207217A1/en
not_active
Expired

1981-10-06
EP
EP81107960A
patent/EP0049847B1/en
not_active
Expired

1981-10-06
DE
DE8181107960T
patent/DE3169418D1/en
not_active
Expired

1981-10-07
US
US06/309,444
patent/US4451455A/en
not_active
Expired – Fee Related

1981-10-07
FI
FI813108A
patent/FI813108L/en
not_active
Application Discontinuation

1981-10-08
AU
AU76150/81A
patent/AU542795B2/en
not_active
Ceased

1981-10-08
NO
NO813407A
patent/NO813407L/en
unknown

1981-10-08
DK
DK446481A
patent/DK446481A/en
not_active
Application Discontinuation

1981-10-08
CA
CA000387612A
patent/CA1172978A/en
not_active
Expired

Cited By (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

AU580973B2
(en)

1984-01-21
1989-02-09
Hoechst Aktiengesellschaft
Novel polypeptides with an «-amylase-inhibiting action, a process for their preparation, their use and pharmaceutical products

Also Published As

Publication number
Publication date

EP0049847B1
(en)

1985-03-20

DE3169418D1
(en)

1985-04-25

ES505959A0
(en)

1982-09-01

EP0049847A2
(en)

1982-04-21

US4451455A
(en)

1984-05-29

FI813108L
(en)

1982-04-10

EP0049847A3
(en)

1982-08-25

ES8207217A1
(en)

1982-09-01

DK446481A
(en)

1982-04-10

NO813407L
(en)

1982-04-13

AU7615081A
(en)

1982-04-22

CA1172978A
(en)

1984-08-21

Información de contacto